Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s12916-016-0732-1 http://scihub22266oqcxt.onion/10.1186/s12916-016-0732-1 C5105252!5105252 !27832792     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\27832792 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       BMC+Med 2016 ; 14 (1 ): 180 Nephropedia Template TP {{tp|p=27832792 |t=2016. Gout: will the "King of Diseases" be the first rheumatic disease to be cured? |pdf=|usr=}}{{27832792 }} gab.com Text Gout: will the "King of Diseases" be the first rheumatic disease to be cured JO: BMC Med http://www.kidney.de/pget.php?&tw=1&pmid=27832792 #FOAvip Gout is the most common inflammatory arthritis in adults in the Western world. Characterized by hyperuricemia and the effects of acute and chronic inflammation in joints and bursa, gout leads to an agonizing, chronically painful arthritis. Arthritis can also be accompanied by urate nephropathy and subcutaneous urate deposits (tophi). Exciting new developments in the last decade have brought back the focus on this interesting, crystal-induced chronic inflammatory condition. New insights include the role of NALP3 inflammasome-induced inflammation in acute gout, the characterization of diagnostic signs on ultrasound and dual-energy computed tomography imaging modalities, the recognition of target serum urate less than 6 mg/day as the goal for urate-lowering therapies, and evidence-based treatment guidelines. A better understanding of disease mechanisms has enabled drug discovery - three new urate-lowering drugs have been approved in the last decade, with several more in the pipeline. We now recognize the important role that environment and genetics play in the causation of gout. A focus on the cardiac, renal, and metabolic comorbidities of gout will help translational research and discovery over the next decade. Twit Text FOAVip Gout: will the "King of Diseases" be the first rheumatic disease to be cured ????BMC Med http://www.kidney.de/pget.php?&tw=1&pmid=27832792 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27832792 #FOAvip English Wikipedia <ref>{{Cite pmid|27832792 }}</ref> Gout: will the "King of Diseases" be the first rheumatic disease to be cured? #MMPMID27832792 Singh JA BMC Med 2016[Nov]; 14 (1 ): 180 PMID27832792 show ga Gout is the most common inflammatory arthritis in adults in the Western world. Characterized by hyperuricemia and the effects of acute and chronic inflammation in joints and bursa, gout leads to an agonizing, chronically painful arthritis. Arthritis can also be accompanied by urate nephropathy and subcutaneous urate deposits (tophi). Exciting new developments in the last decade have brought back the focus on this interesting, crystal-induced chronic inflammatory condition. New insights include the role of NALP3 inflammasome-induced inflammation in acute gout, the characterization of diagnostic signs on ultrasound and dual-energy computed tomography imaging modalities, the recognition of target serum urate less than 6 mg/day as the goal for urate-lowering therapies, and evidence-based treatment guidelines. A better understanding of disease mechanisms has enabled drug discovery - three new urate-lowering drugs have been approved in the last decade, with several more in the pipeline. We now recognize the important role that environment and genetics play in the causation of gout. A focus on the cardiac, renal, and metabolic comorbidities of gout will help translational research and discovery over the next decade. |Adult [MESH] |Arthritis, Rheumatoid/blood/diagnosis/drug therapy [MESH] |Chronic Disease [MESH] |Gout Suppressants/*therapeutic use [MESH] |Gout/*blood/diagnosis/*drug therapy [MESH] |Humans [MESH] |Inflammation/blood/diagnosis/drug therapy [MESH] |Pain/blood/diagnosis/drug therapy [MESH]Gout: will the "King of Diseases" be the first rheumatic disease to be(epmc).pdf DeepDyve Pubget Overpricing